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Abstract
Background: Acute gastroenteritis is a serious cause of child mortality and morbidity in resource-limited countries.
A viral etiology is most common, and rotavirus and norovirus are reported to be the leading causative agents. There
are still few epidemiological data on the simultaneous occurrence of these viruses in Morocco. The aim of this study
was to provide useful epidemiological data on the gastroenteritis associated with rotavirus and norovirus among
children aged less than 5 years.
Methods: From January to December 2011, 335 samples were tested for rotavirus and norovirus using enzyme-linked
immunosorbent assay, reverse-transcription-polymerase chain reaction (RT-multiplex PCR) and real-time RT-PCR. Partial
sequences of the norovirus were phylogenetically analyzed to determine the genotype.
Results: The overall rates of rotavirus and norovirus infections were 26.6% and 16.1%, respectively. Mixed viral
infections were detected in 9 of 335 stool specimens (2.7%).
The most common genotype combination in the rotavirus strains was G1[P8] (51.7%), followed by G2[P4] (10.1%),
G2[P8] (4.5%), G9[P8] (3.4%), G4[P8] (3.4%), and G1[P6] (2.3%). Among patients positive for norovirus, 42 (77.8%) tested
positive for GII and 12 (22.2%) for GI. Thirty-three (78.6%) of the norovirus GII-positive cases were successfully
characterized. Genotype GII.4 was the most prevalent (n = 27; 81.8%), followed by GII.3 (n = 2; 6.1%), GII.13 (n = 2; 6.1%),
GII.16 (n = 1; 3%), and GII.17 (n = 1; 3%).
Conclusion: This study suggests that in Morocco, norovirus is the most frequent cause of acute gastroenteritis after
rotavirus, but further enteric viruses need to be integrated in the surveillance system so that a conclusion could be
drawn.
Keywords: Norovirus, Rotavirus, Acute gastroenteritis, Morocco
Background
Acute gastroenteritis is a very common disease in young
children. It is characterized by massive inflammation of
the gastrointestinal tract membranes, leading to frequent
vomiting and/or diarrhea. Although regarded as a short-
term intestinal disorder, acute gastroenteritis can cause
severe dehydration, leading to further complications and
hospitalization [1-3].
Enteric viruses are recognized as the most significant
etiological agent of acute gastroenteritis, accounting for
approximately 70% of episodes [2]. Four viral families
are commonly associated with acute gastroenteritis: Reovir-
idae (group A rotaviruses), Caliciviridae (noroviruses),
Adenoviridae (adenoviruses 40/41), and Astroviridae (astro-
viruses) [4-6]. Worldwide, rotavirus is considered the most
common viral cause of severe acute gastroenteritis, causing
453,000 deaths and over 2 million hospitalizations among
children under the age of 5 years [7].
Of the two major outer-shell proteins, VP7 defines the
G genotype (G for Glycoprotein) and VP4 defines the P
genotype (P for Protease-sensitive) and these are the
main criteria upon which the dual classification system
for the rotaviruses into P and G serotypes and genotypes
[8]. Currently, 27 G genotypes (G1-G27) and 35 P geno-
types (P[1]-P[35]) have been described for rotavirus [9].* Correspondence: elqazouimaria@yahoo.fr1Immunology–Virology Department, National Institute of Hygiene, Ministry of
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To what extent each genotype defines an antigenically
distinct VP7 or VP4 protein is not known.
Globally, the five most common G/P combinations among
strains infecting humans are G1P[8], G2P[4], G3P[8],
G4P[8], and G9P[8], [10]. Remarkably, the G/P types
of the uncommon strains show wide variation from
one region to the next. For instance, a surveillance
program directed by the World Health Organization
noted that in 2010 the predominant uncommon strains
were G12P[8] and G12P[6] viruses in Southeast Asia;
G2P[6], G3P[6], and G1P[6] viruses in sub-Saharan
Africa; G1P[4] and G2P[8] viruses in the Western Pacific;
and G9P[4] viruses in the Americas [11]. The uncommon
strains that can be spread throughout the world to
become common global strain are difficult to predict.
Indeed, the G9P[8] strains represent the only clear example
of a previously rare G/P genotype combination that
has become dominant within the landscape of globally
circulating rotavirus [12-14].
Norovirus is considered the second most frequent
cause of severe childhood gastroenteritis after rotavirus
[15]. Its prevalence in children with acute gastroenteritis
is in the range of 6–48% [16]. Although more than 30
genotypes, within genogroups GI, GII, and GIV, can
infect humans [17], a single genotype, GII.4, has been
associated with the vast majority of norovirus-related
outbreaks and sporadic cases of gastroenteritis world-
wide [18-20]. The GII.4 norovirus strains undergo con-
tinuous processes of genetic/antigenic diversification and
periodically generate novel strains through the accumu-
lation of punctuate mutations or recombinations, and
novel GII.4 variants emerge every 2–3 years [21,22].
Few data are available on the etiology of acute gastro-
enteritis among young children in Morocco. Only one study
reports the detection of norovirus in shellfish in Morocco.
Norovirus were detected in 30% of samples, with an equal
representation of GI and GII strains, but were much more
frequently found in cockles or clams than in oysters [23].
The report of a national survey performed in 1998, de-
scribing the causes of child deaths, revealed that a high
rate of mortality among children aged less than 5 years
was attributed to diarrheal diseases. The number of these
deaths in 1 year is estimated to be 6000 [24]. In 2006, a
national program for rotavirus surveillance was estab-
lished by the Ministry of Health, in partnership with the
World Health Organization, at four different sites. Data
were collected during a 5-year survey and confirmed the
rotaviral etiology of infective gastroenteritis among chil-
dren aged less than 5 years in Morocco. Subsequently,
isolated rotavirus strains have been investigated and their
molecular epidemiology assessed [25]. These data sup-
ported the introduction of a rotavirus vaccine to the
Moroccan National Immunization Program in 2010. The
vaccine coverage rate was greater than 80% [26].
In countries where the rotaviral vaccine has been in-
troduced, there has been a decline in morbidity related
to rotavirus-associated gastroenteritis. However, a math-
ematical increase of the percentage involved in gastro-
enteritis cases related to norovirus has been reported.
Norovirus has consequently been designated the pre-
dominant cause of gastroenteritis in hospitalized chil-
dren [3,27,28].
To address the paucity of data regarding norovirus in-
fections, we assessed the features of acute gastroenteritis




This prospective study was carried out as part of the
regional rotavirus gastroenteritis surveillance network
of the eastern Mediterranean region of the World Health
Organization. The survey covered four geographically
different regions of Morocco: the University Children’s
Hospital in Rabat (central coastal region), Mohamed
V Hospital in Tanger (northern coastal region), Al Farabi
Hospital in Oujda (eastern region), and Prefectoral
Hospital in Beni-Mellal (southern region).
Specimen collection
In total, 335 fecal specimens were collected from chil-
dren aged less than 5 years who were hospitalized or re-
quired medical care for acute gastroenteritis; Fourty six
were from Rabat, 44 were from Tanger, 25 were from
Beni-Mellal and 220 were from Oujda. The criteria for
gastroenteritis were defined as follows: the acute onset of
three or more loose stools, and/or two or more vomiting
episodes a day that were not related to any other diagnosis,
regardless of the fever conditions; stools with blood traces
were excluded. A complete clinical examination was per-
formed and a questionnaire was completed to collect the
demographic data and clinical histories of the subjects.
Viral investigation
Stools were collected within the first 48 h of admission.
Rotaviral infections were screened with an enzyme-linked
immunosorbent assay (ProSpecT Oxoid, Cambridgeshire,
UK). The sensitivity of the test was 96.6% (83.0–99.9%)
and its specificity was 96.4% (81.6–99.9%). Rotavirus-
reactive samples were stored at −70°C until their molecu-
lar characterization with reverse transcription-polymerase
chain reaction (RT-multiplex PCR) [24,25]. Rotaviral double-
stranded RNA (dsRNA) was extracted from fecal suspen-
sions using the QIAamp Viral RNA Mini Kit (Qiagen,
Hilden, Germany), in accordance with the manufacturer’s
instructions. The dsRNA samples were subjected to semi-
nested multiplex RT-PCR using type-specific primers
for VP7-G1, −G2, −G3, −G4, and -G9, and for VP4-P[4],
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−P[6], −P[8], and −P[10], as described previously [29,30].
All PCR products were examined by gel electrophoresis in
200 ml of 2% agarose gel containing 4 μg of ethidium
bromide. Fragments of the VP7 gene (904 base pairs)
or VP4 gene (876 base pairs) were amplified with the
9 con1-L/VP7-R primers [31] or con2/con3 primers,
respectively [29].
Norovirus infections were assessed using real-time
RT-PCR with oligonucleotide primers and probes as
described previously [32,33], and tested for genogroups GI
and GII. Viral RNA was extracted with the QIAamp Viral
RNA Mini Kit (Qiagen). The norovirus-positive samples
detected with real-time RT-PCR were also analyzed with
conventional RT-PCR to allow sequence analysis. The
primers sets G1SKF/G1SKR and G2SKF/G2SKR [34] were
used to detect a fragment of the capsid gene (region
C) of norovirus genogroups I and II, respectively. RT-PCR
was performed with the OneStep RT–PCR kit (Qiagen),
according to the manufacturer’s instructions.
The PCR products were sequenced with the same
primers as were used for their amplification, with the
ABI Prism BigDye Terminator Ready Reaction Cycle
Sequencing Kit (Applied Biosystems Corporation, Foster
City, CA, USA) and an ABI 3100 Genetic Analyzer (Applied
Biosystems). DNA was sequenced in both directions using
the BigDye Terminator cycling methodology (Applied
Biosystems) and an ABI 3130xl Genetic Analyzer (Applied
Biosystems). Sequences were aligned using ClustalW in-
cluded in the Mega5.2 software [35]. A phylogenetic ana-
lysis was performed with 1000 bootstrapping replicates
using the neighbor-joining method in the tree-builder tool
of the same software.
Nucleotide sequence accession numbers
The nucleotide sequence data were submitted to GenBank
and assigned the accession numbers KJ162359–KJ162391.
Ethical considerations
Informed consent was obtained from the parents or legal
guardians of minors. The Ethics Office from the WHO
and the Moroccan Ministry of Health deemed this sur-
veillance as public health practice.
Statistical analysis
Qualitative variables were compared with χ2 and Fisher’s
tests (EpiInfo version 3.4) and the Mann–Whitney test was
used to compare the Vesikari score values. The level of stat-
istical significance was set at 95%. The Fisher’s test is par-
ticularly useful when the expected value is less than five.
Results
Study group
Among the 335 children enrolled in the study, 184 were
boys and 151 were girls; the sex ratio (male/female) was
1.22. Their ages ranged between 1 and 59 months, with
a median age of 12 months. The main clinical parame-
ters related to acute gastroenteritis recorded in our study
were the period of diarrhea, number of vomiting epi-
sodes, dehydration, and fever.
All the patients studied had diarrhea for periods of 1–15
days, with a median duration of 2 days. The median num-
ber of vomiting episodes was five episodes per day among
all the children, with a range of 0–15 episodes per day.
Sixty-four percent of sufferers showed a high rate of vomit-
ing episodes, and 61.3% experienced fever. Of the children
enrolled, 30% showed moderate dehydration and 40% se-
vere dehydration. Children aged less than 12 months were
the most severely affected, with an estimated dehydration
rate of 49%.
Rotavirus infections
The estimated rate of the rotaviral infection was 26.6%





































Figure 1 Age distribution of rotavirus and norovirus infected cases.
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was between 2 and 59 months, with a median age of
12 months. The great majority (36%) of rotaviral infec-
tions occurred in children aged 6–12 months (Figure 1).
Rotavirus was detected at a higher rate in male stool
samples (53.9%) than in female samples (46.1%). The sex
ratio (male/female) was 1.17. However, there was no sig-
nificant correlation between sex and rotaviral infection.
The median duration of diarrhea experienced by chil-
dren with rotaviral infections was 6 days, and vomiting
episodes occurred at a median rate of six events per day.
Severe dehydration was identified in 44 of 78 patients
infected with rotavirus (56.41%). Twenty-six patients (33.33%)
experienced moderate dehydration, but 8 of the 78 rotavirus-
infected children (10.26%) showed no symptoms of dehy-
dration (Table 1).
Although rotavirus infections were recorded through-
out the year, the number of cases tended to peak in
January (Figure 2).
Norovirus infections
The estimated rate of noroviral infection was 16.1%
(54/335). Rabat and Tanger which are coastal cities had
the highest percentages of norovirus positivity, during the
study period. The difference between the coastal sites and
non-coastal sites was statistically significant (Table 2).
The age of the children affected was between 2 and
48 months, with a median age of 14 months. The high-
est rate was noted in children aged 12–24 months (37%)
(Figure 1). Sample stools from male children showed a
higher rate of norovirus infection (57.4%) than those
from female children (42.6%), but the difference was not
statistically significant. The sex ratio (male/female) of
norovirus patients was 1.35.
The median period of diarrhea among the norovirus-
infected patients was 2 days and the median number of
vomiting episodes was five events per day. Of the 43 de-
tected cases of noroviral infection, severe dehydration
occurred in 13 (30.23%) children and 13 (30.23%) showed
moderate dehydration. No dehydration was recorded in
17 norovirus-infected children (39.53%) (Table 1). Sea-
sonal follow-up of the norovirus-infected patients showed
a peak incidence in June (Figure 2).
Dual norovirus and rotavirus infections
Dual norovirus and rotavirus infections were confirmed
in 9 of 335 (2.7%) patients and were recorded in children
with a median age of 24 months. The median period of
diarrhea was 3 days and the median number of vomiting
episodes was four per day.
Of the nine patients with mixed rotavirus–norovirus
infections, two showed severe dehydration (22.22%) and
four (44.44%) showed moderate dehydration. Three of
the nine coinfected children (33.33%) showed no signs
of dehydration. The majority of rotavirus-norovirus
dual infections were recorded between April and May
(Figure 2).
Rotaviral strain characterization
The rotaviral strains isolated from stool samples were
subjected to molecular characterization, and P and G
types were assigned to 89 isolates with RT-PCR. The most
common genotype combination in the rotaviral strains








Maximum number stools per day
1-3 01 (01.28%) 03 (06.98%) 16 (08.33%)
4-5 21 (26.92%) 12 (27.91%) 63 (32.81%)
≥ 6 56 (71.79%) 28 (65.12%) 113 (58.85%)
Diarrhea duration (days)
1-4 74 (94.87%) 40 (93.02%) 168 (87.50%)
5 03 (03.85%) 00 (00.00%) 14 (07.29%)
≥ 6 01 (01.28%) 43 (06.98%) 10 (05.21%)
Number vomiting episodes per day
0 05 (06.41%) 05 (11.63%) 50 (26.04%)
1 00 (00.00%) 03 (06.98%) 07 (03.65%)
2-4 16 (20.51%) 09 (20.93%) 50 (26.04%)
≥ 5 57 (73.08%) 26 (60.47%) 85 (44.27%)
Vomiting duration (days)
0 05 (06.41%) 05 (11.63%) 50 (26.04%)
1 19 (24.36%) 07 (16.28%) 31 (16.15%)
2 26 (33.33%) 14 (32.56%) 57 (29.69%)
≥ 3 33 (42.31%) 17 (39.53%) 54 (28.13%)
Temperature (°C)
37 25 (32.05%) 17 (39.53%) 79 (41.15%)
37.1-38.4 05 (06.41%) 02 (04.65%) 15 (07.81%)
38.5-38.9 02 (02.56%) 11 (25.58%) 34 (17.71%)
≥ 39.0 46 (58.97%) 13 (30.23%) 64 (33.33%)
Dehydration
Mild 08 (10.26%) 17 (39.53%) 67 (34.90%)
Moderate 26 (33.33%) 13 (30.23%) 55 (28.65%)
Severe 44 (56.41%) 13 (30.23%) 70 (36.46%)
Treatment
Rehydration 07 (08.97%) 12 (27.91%) 45 (23.44%)
Hospitalization 71 (91.03%) 31 (72.09%) 147 (76.56%)
P value
Vesikari score 14.74 12.38 < 0.0001
13.12 12.38 0.26
*89 rotavirus positives samples-(9 co-infections + 2 data missing) = 78.
**54 norovirus positives samples-(9 co-infections + 2 data missing) = 43.
***201 negatives samples-(9 data missing) = 192.
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was G1P[8] (51.7%), followed by G2P[4] (10.1%), G2P[8]
(4.5%), G9P[8] (3.4%), G4P[8](3.4%) and G1P[6] (2.3%). A
high prevalence of mixed strains was found (22.5%) and
2.1% of strains could not be typed (Figure 3).
Noroviral strain characterization and phylogenetic
analysis
Analysis of the genetic diversity of the noroviral strains in
our study showed extensive cocirculation of various geno-
types between January and December 2011. Among the
children positive for norovirus, 42 (77.8%) carried geno-
type GII and 12 (22.2%) carried genotype GI. A subset of
the norovirus samples positive for GII was selected for se-
quence analysis, and 33 were successfully characterized in
region C of the viral genome. The prevailing genotype was
GII.4, accounting for 81.8% of infections (n = 27), whereas
genotypes GII.3 and GII.13 each accounted for 6.1% of in-
fections (n = 2).
Other genotypes, GII.16 and GII.17, were each repre-
sented by one strain (n = 1, 3%). The nucleotide sequence
analysis showed that GII.4 was the most prevalent geno-
type. The variant strain designated “GII.4 variant Sydney
2012” was identified in two samples. A sequence analysis
of these two samples based on a 302-bp sequence of the
capsid gene (C-region) showed 99% identity with the vari-
ant Sydney 2012.
A representative phylogenetic tree based on the nucleo-
tide sequences of the capsid region (C-region) was con-
structed with the neighbor-joining method (Figure 4).
Discussion
In this study, acute gastroenteritis with a rotaviral or
noroviral etiology was investigated in children aged less
than 5 years. This is the first study to investigate both vi-
ruses simultaneously in Morocco. Of the 335 children
with acute gastroenteritis enrolled in the study, 26.6%
(n = 89) tested positive for rotavirus and 16.1% (n = 54)
for norovirus. Our results are consistent with several stud-
ies undertaken elsewhere, indicating that norovirus is the
most common cause of acute gastroenteritis, after rota-
virus [36-38].
After the introduction of a rotavirus vaccine in the
United States, hospitalizations related to acute gastroenter-
itis were 45% lower than 2 years earlier [39]. A substantial
decline in rotavirus-associated acute gastroenteritis was
also observed. Therefore, norovirus is now considered the





























Figure 2 The seasonal distribution of rotavirus and norovirus infections between January and December 2011.
Table 2 Distribution of norovirus positive cases in the 4 sites of the study, in 1 year survey
Provinces Localization area Gastroenteritis samples Number of positive cases Positivity (%) P value
Rabat Coastal cities 46 13 28.3
Tanger 44 90 11 24 25
Beni-Mellal Non-coastal cities 25 1 4 0.001
Oujda 220 245 29 30 13.2
Total 335 54
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In Morocco, prior the implementation of the national
immunization program with rotavirus vaccine, circulat-
ing isolates of rotavirus were genotyped in our facilities.
From June 2006 to May 2009, 1388 stool samples were
collected from children less than 5 years of age admitted
for diarrhea in different regions of Morocco. Overall,
41.7% (579 of 1388) of the stools samples tested were
positive for rotavirus. Genotyping of 548 (95%) samples
demonstrated that G1P[8] (55%) was the most prevalent
strain, followed by G9P[8] (11.3%), G2P[4] (9.1%), G4P[8]
(0.9%), and G3P[8] (0.4%). Several other strains were iden-
tified including G1P[4] (0.2%), G1P[6] (0.9%), G2P[6]
(4.3%), G2P[8] (0.2%), G3P[6] (0.4%), G3P[4] (0.2%),
and G9P[6] (0.2%). A high prevalence of mixed infections
was found (15% of all samples) of which G1G2P[8]
(4%) and G1G3P[8] (3.6%) accounted for the majority.
Considerable diversity of rotavirus genotypes was present
among circulating strains in Morocco [25]. After introduc-
tion of rotavirus vaccination in Morocco, the most com-
mon genotype combination of rotavirus strains was G1[P8]
(51.7%), followed by G2[P4] (10.1%), G2[P8] (4.5%),
G9[P8] (3.4%), G4[P8] (3.4%) and G1[P6] (2.3%). A high
prevalence of mixed strains (22.5% of the total) was found.
The prevalence of rotavirus gastroenteritis decreased
from 41.7% to 26.6%. The involvement of the vaccine
introduction in the decreasing of the prevalence and
the changing in molecular diversity of rotavirus strains
in Morocco needs further study. The selective pressures
coming from the vaccine may be subtle; many years
are required before making a conclusion concerning this
phenomenon [41].
Because the Moroccan childhood immunization pro-
gram was implemented with a rotavirus vaccine in 2010,
it is likely that norovirus-associated gastroenteritis will
increase relative to rotavirus-associated gastroenteritis,
as described by Patel et al. [15] and Payne et al. [27]. A
prospective survey is required to determine the point at
which the switch in this trend occurs.
Both viruses were detected in all age groups examined
in this study. The peak detection rate occurred between
6 and 12 months of age for rotavirus, with a median age
of 12 months, and between 12 and 24 months of age for
norovirus, with a median age of 14 months, as was also
shown in a French study [36]. These findings confirm
that both viruses usually occur in early childhood, which
may indicate that protective immunity is present after
the age of 2 years [42], and also highlights the import-
ance of implementing prevention strategies in the early
years of life. The overall severity score was significantly
higher for rotavirus gastroenteritis than for norovirus in-
fections. Similar results have been reported in Spain,
Poland, and Libya [3,37,43]. Those studies showed that
rotavirus-infected children experienced longer periods of
diarrhea and were more severely dehydrated than chil-
dren infected with norovirus.
During this 1-year survey, cases of rotavirus- and
norovirus-associated gastroenteritis were recorded through-
out the year, except in October and February, when no case
of rotavirus and norovirus was detected, respectively. We
observed one peak for rotavirus in January and two peaks
for norovirus, in June. The increased rates of noroviral in-
fection in spring and summer have been documented pre-
viously in Libya and Spain [43,44]. The summertime peak
may be explained by the emergence of a new virus variant,
as reported by Lopman et al. [45].
In Morocco, spring and summer seasons are com-
monly associated with increased consumption of seafood
particularly oysters, which is known as a risk factor for
acquiring norovirus infection [23,46]. Rabat and Tanger
which are coastal cities had the highest percentages of
norovirus positivity, during the study period. The study


















Figure 3 Distribution of G/P genotypes combinations in Morocco, from January to December 2011.
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Norovirus GII is predominantly responsible for gastro-
enteritis worldwide, as described in most studies [47-52],
and our findings (77.8% GII and 22.2% GI) are
consistent with these findings. A subset of norovirus-
positive GII samples (n = 33) was sequenced and














































Figure 4 Phylogenic analysis of norovirus sequences. The genetic relationship is based on a 322-nucleotides fragment of Region C (VP1). The
tree was generated using the neighbor-joining method and the bootstrap values from 1000 replicates were shown on each branch. The
sequence accession numbers are given in parentheses. The reference strains were from NCBI Genbank: Bristol(X76716), Fayetteville (AY113106),
MinireovirusTV24 (U02030), CS-E1/2002/USA (AY502009), Tiffin-1999 (AY502010) and Variant Sydney 2012/FRA (KF008239).
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the predominant genotype, followed by GII.3 (n = 2) and
GII.13 (n = 2), GII.16 (n = 1), and GII.17 (n = 1). Several
global studies have demonstrated the prevalence of the
GII.4 genotype and our results are consistent with them
[18,19,43,53].
Unexpectedly, our results showed the presence of the
GII.4 variant Sydney2012 in two samples, from the
northern region of Morocco (GenBank accession num-
bers KJ162365 [Tanger/M462/2011/MOR] and KJ162362
[Tanger/M687/2011/MOR]). This variant was first iden-
tified in March 2012 in Australia [54] and in December
2012 in Denmark [55], one year after the sampling for
our study. This supports the idea that patients with
sporadic gastroenteritis are a reservoir for emerging epi-
demic noroviral strains [52].
Dual rotavirus-norovirus infections were detected in
2.7% of our study samples. Approximately the same rate
was reported (2.1%) in a Polish study [3], but our rate is
lower than that reported in France by Tran et al. [36].
As reported in the present study and the French study
[36], there was no significant correlation between the se-
verity of gastroenteritis and combined infections.
Conclusion
Our findings highlight the need to strengthen the sur-
veillance of gastroenteritis and extend it to others regions
in Morocco. This will allow us to monitor changes in the
epidemiology of rotavirus- and norovirus-associated gastro-
enteritis and to identify dynamic shifts in the circulating
strains.
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